Nuveen, LLC Fennec Pharmaceuticals Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Nuveen, LLC holds 26,006 shares of FENC stock, worth $161,497. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,006Holding current value
$161,497% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding FENC
# of Institutions
70Shares Held
15.1MCall Options Held
10KPut Options Held
83.8K-
Southpoint Capital Advisors LP New York, NY4.08MShares$25.3 Million0.71% of portfolio
-
Sonic Gp LLC Honolulu, HI2.41MShares$14.9 Million33.54% of portfolio
-
Solas Capital Management, LLC Darien, CT2.25MShares$14 Million11.1% of portfolio
-
Black Rock Inc. New York, NY1.19MShares$7.37 Million0.0% of portfolio
-
Dg Capital Management, LLC New York, NY1.11MShares$6.92 Million2.94% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $162M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...